サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1619819

ファーマコビジランスアウトソーシングの世界市場レポート 2024年

Pharmacovigilance Outsourcing Global Market Report 2024

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ファーマコビジランスアウトソーシングの世界市場レポート 2024年
出版日: 2024年12月20日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ファーマコビジランスアウトソーシング市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR17.4%で117億1,000万米ドルに成長します。予測期間に予測される成長は、生物製剤とバイオシミラーの拡大、個別化医療への注目の高まり、実臨床エビデンスへの要求の高まり、薬剤安全性プロファイルの複雑化、患者中心のケアの重視の強化などに起因しています。この期間に予想される主要動向には、ビッグデータ分析の利用の増加、パートナーシップとコラボレーションの増加、クラウドベースのファーマコビジランスソリューションの採用、ファーマコビジランスとデジタルヘルスプラットフォームの統合、遺伝子治療に特化したファーマコビジランスサービスの開発などがあります。

ファーマコビジランスアウトソーシング市場の成長は、臨床検査の増加によって牽引されると予測されます。臨床検査とは、新しい治療法、医薬品、医療機器の安全性、有効性、潜在的な副作用を評価するための調査研究です。臨床検査の増加は、精密医療の重視、慢性疾患の蔓延、規制当局の支援、研究のグローバリゼーションなどの要因によって促進されています。臨床検査におけるファーマコビジランスのアウトソーシングは、専門的な専門知識とリソースを活用することで医薬品の安全性モニタリングを改善し、規制遵守を確保するとともに効率を高めています。例えば、2023年11月、英国製薬工業協会（Association of the British Pharmaceutical Industry）は、英国における産業主催の臨床検査件数が4.3%微増し、2021年の394件から2022年には411件に増加すると報告しました。このように、臨床検査数の増加がファーマコビジランスアウトソーシング市場の拡大を牽引しています。

ファーマコビジランスアウトソーシング市場の主要参入企業は、ファーマコビジランス症例処理と安全性データ管理を最適化するために、クラウドベースのデータレイクプラットフォームなどの革新的なソリューションの開発に注力しています。これらのプラットフォームは、臨床研究レジストリを強化し、規制コンプライアンスを確保するのに役立ちます。クラウドベースのデータレイクプラットフォームは、大量の生データを必要な時までネイティブフォーマットで保存・管理する一元化されたリポジトリです。例えば、2023年12月、米国を拠点とするバイオテクノロジーと実験機器企業であるThermo Fisher Scientific Inc.は、CorEvidenceを発表しました。このプラットフォームは、ファーマコビジランス症例処理を合理化し、複数のデータソースを管理することで、臨床研究登録を改善するように設計されています。有害事象のコード化、分類、報告を最適化し、スケーラブルでコンプライアンスに対応した監査可能な安全性管理を提供するとともに、様々な治療領域における長期的な承認後安全性検査をサポートします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界のファーマコビジランスアウトソーシング市場：促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界のファーマコビジランスアウトソーシング市場の実績：規模と成長、2018～2023年
  • 世界のファーマコビジランスアウトソーシング市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界のファーマコビジランスアウトソーシング市場：タイプ別、実績と予測、2018～2023年、2023～2028年、2033年
  • 薬剤有害反応捕捉（ADR）
  • ケース処理
  • 報告と提出
  • レポートの公開
  • 品質チェック
  • リスク管理
  • ナレッジマネジメント
  • アーキテクチャの実現
  • 世界のファーマコビジランスアウトソーシング市場：サービスプロバイダー別、実績と予測、2018～2023年、2023～2028年、2033年
  • 契約研究機関
  • 業務処理アウトソーシング
  • 世界のファーマコビジランスアウトソーシング市場：エンドユーザー別、実績と予測、2018～2023年、2023～2028年、2033年
  • 製薬産業
  • 研究組織
  • その他

第7章 地域別・国別分析

  • 世界のファーマコビジランスアウトソーシング市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界のファーマコビジランスアウトソーシング市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ファーマコビジランスアウトソーシング市場：競合情勢
  • ファーマコビジランスアウトソーシング市場：企業プロファイル
    • ACCENTURE PLC
    • International Business Machines Corporation（IBM）
    • Tata Consultancy Services
    • Capgemini SE
    • Cognizant Technology Solutions Corporation

第31章 その他の大手企業と革新的企業

  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings（Labcorp）
  • Wipro Limited
  • ICON PLC
  • Syneos Health
  • Genpact limited
  • Parexel International Corp
  • Veeva Systems Inc.
  • Medpace Holdings Inc.
  • ProPharma Group
  • Pharmalex GmbH
  • PrimeVigilance Ltd.
  • Global Pharma Tek
  • Veristat LLC
  • United BioSource LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

目次
Product Code: r20806

Pharmacovigilance outsourcing involves hiring external service providers to manage and perform pharmacovigilance activities for pharmaceutical companies. These activities encompass detecting, assessing, understanding, and preventing adverse effects or other drug-related issues.

The primary types of pharmacovigilance outsourcing include adverse drug reaction capture (ADR), case processing, reporting and submission, report publishing, quality checks, risk management, knowledge management, and enabling architecture. ADR capture involves identifying, documenting, and analyzing harmful or unintended reactions to medications to ensure drug safety and enhance patient care. These services are typically offered by contract research organizations and business process outsourcing companies. The main users of these outsourced services include the pharmaceutical industry, research organizations, and other stakeholders.

The pharmacovigilance outsourcing market research report is one of a series of new reports from The Business Research Company that provides pharmacovigilance outsourcing market statistics, including pharmacovigilance outsourcing industry global market size, regional shares, competitors with a pharmacovigilance outsourcing market share, detailed pharmacovigilance outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacovigilance outsourcing industry. This pharmacovigilance outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmacovigilance outsourcing market size has grown rapidly in recent years. It will grow from $5.25 billion in 2023 to $6.16 billion in 2024 at a compound annual growth rate (CAGR) of 17.3%. The growth during the historic period can be attributed to the rise in drug development activities, stringent regulatory requirements, a higher incidence of adverse drug reactions, growing concerns about patient safety, and an increase in outsourcing by small and mid-sized companies.

The pharmacovigilance outsourcing market size is expected to see rapid growth in the next few years. It will grow to $11.71 billion in 2028 at a compound annual growth rate (CAGR) of 17.4%. The growth projected for the forecast period can be attributed to the expansion of biologics and biosimilars, a heightened focus on personalized medicine, a growing demand for real-world evidence, the increasing complexity of drug safety profiles, and a stronger emphasis on patient-centric care. Key trends expected in this period include the increased use of big data analytics, a rise in partnerships and collaborations, the adoption of cloud-based pharmacovigilance solutions, the integration of pharmacovigilance with digital health platforms, and the development of specialized pharmacovigilance services for gene therapies.

The growth of the pharmacovigilance outsourcing market is anticipated to be driven by the increasing number of clinical trials. Clinical trials are research studies designed to assess the safety, effectiveness, and potential side effects of new treatments, drugs, or medical devices. The rise in clinical trials is fueled by factors such as the emphasis on precision medicine, the growing prevalence of chronic diseases, regulatory support, and the globalization of research. Outsourcing pharmacovigilance in clinical trials improves drug safety monitoring by utilizing specialized expertise and resources to ensure regulatory compliance and enhance efficiency. For instance, in November 2023, the Association of the British Pharmaceutical Industry reported a slight increase of 4.3% in the number of industry-sponsored clinical trials in the UK, rising from 394 in 2021 to 411 in 2022. Thus, the growing number of clinical trials is driving the expansion of the pharmacovigilance outsourcing market.

Key players in the pharmacovigilance outsourcing market are focusing on developing innovative solutions, such as cloud-based data lake platforms, to optimize pharmacovigilance case processing and safety data management. These platforms help enhance clinical research registries and ensure regulatory compliance. A cloud-based data lake platform is a centralized repository that stores and manages large volumes of raw data in its native format until needed. For example, in December 2023, Thermo Fisher Scientific Inc., a U.S.-based biotechnology and laboratory equipment company, introduced CorEvidence. This platform is designed to improve clinical research registries by streamlining pharmacovigilance case processing and managing multiple data sources. It optimizes the coding, classification, and reporting of adverse events, offering scalable, compliant, and auditable safety management while supporting long-term post-authorization safety studies across various therapeutic areas.

In November 2023, Permira Advisers LLP, a UK-based investment firm, acquired Ergomed PLC for $0.904 billion. This acquisition is intended to support Ergomed's growth by leveraging Permira's expertise, capital, and global network to enhance Ergomed's commercial, technological, and geographic capabilities and facilitate strategic acquisitions in the contract research organization (CRO) and pharmacovigilance (PV) sectors. Ergomed PLC, based in the UK, offers drug development services, including pharmacovigilance.

Major companies operating in the pharmacovigilance outsourcing market are ACCENTURE PLC, International Business Machines Corporation (IBM), Tata Consultancy Services, Capgemini SE, Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., Laboratory Corporation of America Holdings (Labcorp), Wipro Limited, ICON PLC, Syneos Health, Genpact limited, Parexel International Corp, Veeva Systems Inc., Medpace Holdings Inc., ProPharma Group, Pharmalex GmbH, PrimeVigilance Ltd., Global Pharma Tek, Veristat LLC, United BioSource LLC, Lambda Therapeutic Research, ArisGlobal, Biomapas

North America was the largest region in the pharmacovigilance outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacovigilance outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmacovigilance outsourcing market includes revenues earned by entities by providing services such as pharmacovigilance database management, assessment services, medical information call center services, regulatory consulting and strategy services, pharmacovigilance compliance and auditing, and aggregate reporting and benefit-risk evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmacovigilance Outsourcing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmacovigilance outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmacovigilance outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmacovigilance outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Adverse Drug Reaction Capture (ADR); Case Processing; Reporting And Submission; Report Publishing; Quality Check; Risk Management; Knowledge Management; Enabling Architecture
  • 2) By Service Provider: Contract Research Organization; Business Processing Outsourcing
  • 3) By End User: Pharmaceutical Industry; Research Organization; Others End Users
  • Companies Mentioned: ACCENTURE PLC; International Business Machines Corporation (IBM); Tata Consultancy Services; Capgemini SE; Cognizant Technology Solutions Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmacovigilance Outsourcing Market Characteristics

3. Pharmacovigilance Outsourcing Market Trends And Strategies

4. Pharmacovigilance Outsourcing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pharmacovigilance Outsourcing Market Size and Growth

  • 5.1. Global Pharmacovigilance Outsourcing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pharmacovigilance Outsourcing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pharmacovigilance Outsourcing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmacovigilance Outsourcing Market Segmentation

  • 6.1. Global Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Adverse Drug Reaction Capture (ADR)
  • Case Processing
  • Reporting And Submission
  • Report Publishing
  • Quality Check
  • Risk Management
  • Knowledge Management
  • Enabling Architecture
  • 6.2. Global Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Contract Research Organization
  • Business Processing Outsourcing
  • 6.3. Global Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Industry
  • Research Organization
  • Others End Users

7. Pharmacovigilance Outsourcing Market Regional And Country Analysis

  • 7.1. Global Pharmacovigilance Outsourcing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pharmacovigilance Outsourcing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmacovigilance Outsourcing Market

  • 8.1. Asia-Pacific Pharmacovigilance Outsourcing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmacovigilance Outsourcing Market

  • 9.1. China Pharmacovigilance Outsourcing Market Overview
  • 9.2. China Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmacovigilance Outsourcing Market

  • 10.1. India Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmacovigilance Outsourcing Market

  • 11.1. Japan Pharmacovigilance Outsourcing Market Overview
  • 11.2. Japan Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmacovigilance Outsourcing Market

  • 12.1. Australia Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmacovigilance Outsourcing Market

  • 13.1. Indonesia Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmacovigilance Outsourcing Market

  • 14.1. South Korea Pharmacovigilance Outsourcing Market Overview
  • 14.2. South Korea Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmacovigilance Outsourcing Market

  • 15.1. Western Europe Pharmacovigilance Outsourcing Market Overview
  • 15.2. Western Europe Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmacovigilance Outsourcing Market

  • 16.1. UK Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmacovigilance Outsourcing Market

  • 17.1. Germany Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmacovigilance Outsourcing Market

  • 18.1. France Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmacovigilance Outsourcing Market

  • 19.1. Italy Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmacovigilance Outsourcing Market

  • 20.1. Spain Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmacovigilance Outsourcing Market

  • 21.1. Eastern Europe Pharmacovigilance Outsourcing Market Overview
  • 21.2. Eastern Europe Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmacovigilance Outsourcing Market

  • 22.1. Russia Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmacovigilance Outsourcing Market

  • 23.1. North America Pharmacovigilance Outsourcing Market Overview
  • 23.2. North America Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmacovigilance Outsourcing Market

  • 24.1. USA Pharmacovigilance Outsourcing Market Overview
  • 24.2. USA Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmacovigilance Outsourcing Market

  • 25.1. Canada Pharmacovigilance Outsourcing Market Overview
  • 25.2. Canada Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmacovigilance Outsourcing Market

  • 26.1. South America Pharmacovigilance Outsourcing Market Overview
  • 26.2. South America Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmacovigilance Outsourcing Market

  • 27.1. Brazil Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmacovigilance Outsourcing Market

  • 28.1. Middle East Pharmacovigilance Outsourcing Market Overview
  • 28.2. Middle East Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmacovigilance Outsourcing Market

  • 29.1. Africa Pharmacovigilance Outsourcing Market Overview
  • 29.2. Africa Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmacovigilance Outsourcing Market Competitive Landscape And Company Profiles

  • 30.1. Pharmacovigilance Outsourcing Market Competitive Landscape
  • 30.2. Pharmacovigilance Outsourcing Market Company Profiles
    • 30.2.1. ACCENTURE PLC
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. International Business Machines Corporation (IBM)
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Tata Consultancy Services
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Capgemini SE
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Cognizant Technology Solutions Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pharmacovigilance Outsourcing Market Other Major And Innovative Companies

  • 31.1. IQVIA Holdings Inc.
  • 31.2. Laboratory Corporation of America Holdings (Labcorp)
  • 31.3. Wipro Limited
  • 31.4. ICON PLC
  • 31.5. Syneos Health
  • 31.6. Genpact limited
  • 31.7. Parexel International Corp
  • 31.8. Veeva Systems Inc.
  • 31.9. Medpace Holdings Inc.
  • 31.10. ProPharma Group
  • 31.11. Pharmalex GmbH
  • 31.12. PrimeVigilance Ltd.
  • 31.13. Global Pharma Tek
  • 31.14. Veristat LLC
  • 31.15. United BioSource LLC

32. Global Pharmacovigilance Outsourcing Market Competitive Benchmarking

33. Global Pharmacovigilance Outsourcing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmacovigilance Outsourcing Market

35. Pharmacovigilance Outsourcing Market Future Outlook and Potential Analysis

  • 35.1 Pharmacovigilance Outsourcing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pharmacovigilance Outsourcing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pharmacovigilance Outsourcing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer